fair access for safe and timely generics act of 2015 or the fast generics act of 2015 .
this bill amends the federal food, drug, and cosmetic act to require the environmental protection agency (epa) to establish a program to provide competitive access to approved drugs and licensed biological products. the bill also amends the public health service act to revise requirements for the timely development of drugs and generic drugs and biosimilars by eligible product developers to develop and test new institutions.